Related Experiment Video
Updated: Apr 6, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
MetSim: Integrated Programmatic Access and Pathway Management for Xenobiotic Metabolism Simulators
Louis Groff1, Antony Williams1, Imran Shah1
1Center for Computational Toxicology and Exposure (CCTE), Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711, United States.
MetSim is a new framework for comparing xenobiotic metabolism simulators. Combining multiple tools improved metabolite prediction accuracy, aiding chemical risk assessment.
Area of Science:
- Environmental Chemistry
- Computational Toxicology
- Bioinformatics
Background:
- Evaluating environmental chemical risks requires understanding xenobiotic metabolism.
- Existing metabolite simulation tools have varied formats and limited comparability.
- Comparing the performance and coverage of these tools is a significant challenge.
Purpose of the Study:
- To develop a standardized framework, MetSim, for harmonizing and comparing in silico metabolic simulators.
- To create a system for evaluating the performance and coverage of different metabolic simulation tools.
Main Methods:
- Developed a graph-based schema for harmonizing metabolism data.
- Implemented the schema in MongoDB for storing and retrieving metabolic graphs.
- Integrated four simulators: BioTransformer, OECD Toolbox, EPA's CTS, and TIMES.
- Compiled a dataset of 112 drugs and 432 metabolites for prediction.
- Evaluated simulator performance using recall and precision metrics.
Main Results:
- Individual simulator recall ranged from 0.39 to 0.54.
- Combining predictions from all simulators increased overall recall to 0.73.
- MetSim facilitated efficient derivation of insights into simulator performance.
Conclusions:
- MetSim provides a valuable platform for assessing in silico metabolic simulators.
- Standardized comparison aids in selecting appropriate tools for chemical risk evaluation.
- Future efforts can leverage MetSim to evaluate other datasets and improve predictive accuracy.
Related Concept Videos
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

